Bill Baruch moves on small caps, the how and why.
Bill Baruch, founder and president of Blue Line Capital, joins CNBC’s “Halftime Report” to detail his latest portfolio move in the IJR. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
The AI data center debt dilemma: Here’s what you need to know
The Investment Committee debate whether the overall AI story is still intact. Tune in. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Where to Buy Oracle
In a post-Fed market, Bill Baruch and the committee debate the full story behind Oracle’s growth and post-earnings decline. Tune in to hear why Bill doesn’t think this is the end. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to […]
Energy is Breaking Out, How to Play It
From Exxon’s resilience to gold and silver’s moves, Bill Baruch lays out the fundamentals he’s watching for both equities and commodities. Tune in for his insights. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Bill Baruch buys Applovin, Intuitive Surgical, Sofi, Micron and Vertiv
Bill Baruch, founder & president at Blue Line Capital, joins CNBC’s ‘Halftime Report’ to detail his latest portfolio buys. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
The Committees Energy Strategy
Tune in to learn about the Committee’s Energy Strategy and what’s driving their outlook! Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Trade Tracker: Bill Baruch buys more Amgen
Bill Baruch, founder and president at Blue Line Capital, joins CNBC’s “Halftime Report” to detail his latest Amgen purchase. The Investment Committee debate the biotech sector. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Is a greater rotation coming? Here’s what experts say
The Investment Committee debate whether a greater rotation is coming and if a December rate cut is on the table. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Trade Tracker: Bill Baruch buys more Amazon and Uber
Bill Baruch, founder & president at Blue Line Capital, joins CNBC’s ‘Halftime Report’ to detail his latest portfolio moves. The Investment Committee debate the trades. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Trade Tracker: Bill Baruch buys more Coinbase
Bill Baruch, Founder and president at Blue Line Capital, joins CNBC’s “Halftime Report” to explain why he’s buying more Coinbase. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.